529 results on '"Windyga J"'
Search Results
152. Podłoże genetyczne wrodzonego niedoboru czynnika XI w Polsce
153. Nabyty zespół von Willebranda (AVWF) u chorych z nadpłytkowością samoistną (ET)
154. Nabyty niedobór czynnika X u chorej z guzem pęcherza moczowego i przewlekłą niewydolnością nerek
155. Acquired idiopathic thrombotic thrombocytopenia purpura – a case report of effective therapy with steroids and plasmapheresis
156. Homozygotyczna mutacja typu Leiden u pacjentki uprawiającej wyczynowo sport
157. Nabyty zespół von Willebranda u pacjenta ze szpiczakiem plazmocytowym
158. Analiza kliniczna homozygotycznych nosicieli mutacji typu Leiden genu czynnika V
159. Final results of a prospective-multicentre study to evaluate pharmacokinetics, efficacy and safety of a solvent-detergent treated and 15 nanometer-filtered plasma-derived factor VIII
160. Pregnancy in Upshaw-Schulman syndrome
161. Management of factor VII‐deficient patients undergoing joint surgeries – preliminary results of locally developed treatment regimen
162. Recommendations for assessment, monitoring and follow-up of patients with haemophilia
163. Registry of inherited bleeding disorders in Poland – current status and potential role of the HemoRec database
164. Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of the rFVIIa Variant (BAY 86–6150) In Hemophilia A or B with or without Inhibitors.
165. Efficacy, Safety and Tolerability of a Novel High-Purity, Double Virus-Inactivated VWF/FVIII-Concentrate in the Treatment of Von Willebrand Disease (VWD) - Clinical Experience in the Treatment of Bleeding and Surgery.
166. Efficacy and safety of a recombinant factor IX (Bax326)a in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
167. Pregnancy in Upshaw-Schulman syndrome.
168. BDDrFVIII (Moroctocog alfa [AF-CC]) for surgical haemostasis in patients with haemophilia A: results of a pivotal study.
169. Modulation of factor VIII-specific memory B cells.
170. Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate.
171. European curriculum for thrombosis and haemostasis.
172. Phenotype – genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.
173. Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
174. Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A.
175. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa
176. Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia
177. Total elbow arthroplasty in patient with severe von Willebrand disease.
178. Short and long-term management of haemophilia A patient requiring heart valve surgery.
179. Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the rFVIIa variant (BAY 86-6150) in hemophilia A or B with or without inhibitors
180. Increased activity of factor VIII and venous thromboembolism,Zwiȩkszona aktywność czynnika VIII a żylna choroba zakrzepowo-zatorowa
181. Acquired thrombotic thrombocytopenic purpura (TTP) in patient with heterozygous MTHFR C677T mutation and hyperhomocysteinemia: a case report
182. Course of pregnancy, labour and perioperative management of two patients with bernard-soulier syndrome - case reports and literature review
183. Collagen binding assay in the laboratory diagnosis of von Willebrand disease
184. Part III: Principles of inherited platelet function disorders management,Czȩść III: Zasady postȩpowania we wrodzonych zaburzeniach czynności płytek krwi
185. Consequences of long-lasting HCV infection in haemophiliacs: what can we learn from ultrasonography (US) and endoscopy evaluation?
186. von Willebrand factor plasma levels in patients with essential thrombocythaemia
187. Study of intrafamilial transmission of hepatitis viruses in haemophilia population
188. Therapeutic properties and safety of recombinant factor VIII and factor IX
189. A scoring system for thromboembolic risk assessment in surgery, developed by the Polish Working Group, on the basis of the scoring system developed by Joseph Caprini,Skala punktowa opracowana przez Polska̧ Grupȩ Robocza̧ na podstawie skali Josepha Capriniego dotycza̧ca oceny stopnia zagrożenia rozwoju powikłań zakrzepowo-zatorowych w chirurgii
190. A scoring system for thromboembolic risk assessment in patients hospitalised on non-surgical wards developed by the Polish Working Group,Skala punktowa opracowana przez Polska̧ Grupȩ Robocza̧ do oceny stopnia zagrożenia powikłaniami zakrzepowo-zatorowymi u pacjentów hospitalizowanych na oddziałach zachowawczych
191. Polish guidelines for the management of rare clotting factor deficiencies,Polskie zalecenia postȩpowania w rzadkich niedoborach osoczowych czynników krzepni̧cia
192. GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients,Markery zakazenia wirusami GBV-C/HGV i TTV u chorych na hemofilif, oraz u dawców krwi w Polsce
193. Guidelines for the prevention and treatment of venous thromboembolism in patients with cancers treated conservatively,Wytyczne dotyczace profilaktyki i leczenia zylnej choroby zakrzepowo-zatorowej u chorych na nowotwory poddawanych leczeniu zachowawczemu
194. Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs,Czestość zakazeń HCV, HBV i HIV u chorych na ciezka hemofilie w Polsce: porównanie chorych urodzonych przed i po 1991 roku
195. Lupus anticoagulant - hypoprothrombinemia syndrome in patient - a case report
196. Cytomegalovirus-induced immune thrombocytopenia,Immunologiczna małopłytkowość indukowana wirusem cytomegalii
197. Course of pregnancy, labour and perioperative management of a patient with Bernard-Soulier Syndrome - case report and literature review
198. Part I: Principles of haemophilia A and B management,Czȩść I: Zasady postȩpowania w hemofilii A i B
199. Wytyczne postȩpowania w nagłych i planowych sytuacjach klinicznych, moga̧cych zaistnieć u chorych leczonych doustnymi, bezpośrednimi inhibitorami aktywnego czynnika X oraz aktywnego czynnika II
200. Factor V Leiden in the absence of apc resistance in a patient after liver transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.